Showing results (6261-6270 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|September 24, 2004
Negative glucocorticoid receptor response elements and their role in glucocorticoid actionA Dostert, T HeinzelCurrent Pharmaceutical Design|September 24, 2004
The NF-kappaB pathway as a potential target for autoimmune disease therapySusanne Bacher, M Lienhard SchmitzCurrent Pharmaceutical Design|September 24, 2004
Antimicrobial peptides: mediators of innate immunity as templates for the development of novel anti-infective and immune therapeuticsP S Hiemstra, B A Fernie-King, J McMichael, et al.Current Pharmaceutical Design|July 29, 2004
G protein-coupled receptor fusion proteins in drug discoveryG Milligan, G-J Feng, R J Ward, et al.Current Pharmaceutical Design|July 29, 2004
Allosteric modulation of G protein-coupled receptorsL T May, V A Avlani, P M Sexton, et al.Current Pharmaceutical Design|July 29, 2004
Bivalent ligands for G protein-coupled receptorsWilliam S MesserCurrent Pharmaceutical Design|July 29, 2004
Therapy of chronic hepatitis C virus infection in HIV co-infected peopleP Fabris, E Barnes, G Tositti, et al.Current Pharmaceutical Design|July 29, 2004
Membrane disrupting lytic peptides for cancer treatmentsCarola Leuschner, William HanselCurrent Pharmaceutical Design|July 29, 2004
Cancer-specific ligands identified from screening of peptide-display librariesT MoriCurrent Pharmaceutical Design|October 27, 2005
Immunity to tumour antigensGeng Li, Selman A Ali, Stephanie E B McArdle, et al.Pageof 1,008